Please Note: This trial is no longer enrolling new participants
NF110: Open-label, Phase 2 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
| Protocol No. | PHO-DOD-NF110 | Scope | National |
|---|---|---|---|
| Principal Investigator | Steven Rhodes | Treatment Type | Treatment |
| Age Group | Adults and Children | Phase | Phase II |
